| Septerna Therapeutics (NASDAQ: SEPN) |
G protein-coupled receptor (GPCR); Therapeutics |
J.P. Morgan Securities, Cantor Fitzgerald, TD Securities, Wells Fargo Securities |
10/24/2024 |
$18.00 |
$288 million |
$18 |
| Baylis Medical (TSX: BAY) |
Medical devices; Cardiac electrophysiology |
RBC Capital Markets, National Bank Financial, Stifel GMP |
10/09/2024 |
CAD$15.00 |
CAD$94.5 million |
CAD$14 – 16 |
| Tranzyme Pharma (NASDAQ: TZYM) |
Small molecule therapeutics; Cardiometabolic diseases |
J.P. Morgan Securities, SVB Securities, Wedbush Securities |
09/26/2024 |
$16.00 |
$30 million |
$14 – $16 |
| Spero Therapeutics (NASDAQ: SPRO) |
Anti-infectives; Bacterial infections |
J.P. Morgan Securities, Jefferies, Stifel GMP |
08/29/2024 |
$14.00<
|